Rapid assessment of injection practices in Mongolia

American Journal of Infection Control

Volumn 32, Issue 1, 2004, Pages 31-37

  Logez, Sophie ^a   Soyolgerel, Gochoo ^b   Fields, Rebecca ^c   Luby, Steve ^d   Hutin, Yvan ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MINISTRY OF HEALTH   (Canada)

^c Academy for Education Development   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; FEMALE; HEALTH CARE FACILITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; INJECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MONGOLIA; NEEDLE; NEEDLESTICK INJURY; PUBLIC HEALTH SERVICE; REVIEW; SAFETY; VIRUS TRANSMISSION;

EID: 1042279547     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2003.06.006     Document Type: Article

References (15)

1. Hauri AM, Armstrong GL, Hutin YJF. Contaminated injections in health care settings. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2003.
2. Reeler AV. Anthropological perspectives on injections: a review. Bulletin of the World Health Organization 2000;78:135-43.
3. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and HIV through unsafe injection in the developing world: model-based regional estimates. Bulletin of the World Health Organization 1999;77:801-7.
4. World Health Organization. High frequency of therapeutic injections, Republic of Moldova. Wkly Epidemiol Rec 1999;11:84-6.
5. Dashdelger A. WHO collaborating center for viral hepatitis. Ulaan Baatar, Mongolia: WHO. WHO Western Pacific region document WPR/EMC/CDC, 98:15.
6. Luby SP, Qamruddin K, Shah AA, Omair A, Pasha O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997;119:349-56.
7. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-91.
8. Injection practices: rapid assessment and response guide. Geneva: World Health Organization; 2000. WHO document WHO/BCT/ 02.11.
9. Prawitasari Hadiyono JE, Suryawati S, Danu SS, Sunartono, Santoso B. Interactional group discussion: results of a controlled trial using a behavioural intervention to reduce the use of injections in public health facilities. Soc Sci Med 1996;42:1177-83.
10. Davaasuren D, Dahgwadori Y, Nymadawa P, Gantuya S, Sarangoo G. Survey results of prevalence for viral hepatitis B, C and D markers among the children in Ulaanbaatar. Mongolian Med Sci 2000;4:21-4.
11. Kidd-Lunggren K, Broman E, Ekvall H, Gustavson O. Nosocomial transmission of hepatitis B virus infection through multiple-dose vials. J Hosp Infect 1999;43:57-61.
12. Dentinger CM, Hutin YJF, Pasat L, Mihilescu I, Mast EE, Margolis HS. Knowledge and practices of nurses regarding injection safety and use of universal precautions, Vilcea district, Romania. Abstract presented at the annual meeting of the Society for Health-Care Epidemiology of America (SHEA); April 1999; San Francisco, CA.
13. Order #A/124, 1995. Appendix 4. Mongolia: Ministry of Health; 1995.
14. Hofman CA. The WHO injection safety assessment tool: first results. In: Safe Injection Global Network (SIGN) annual meeting report. Geneva: World Health Organization; 2000. WHO document WHO/BCT/DCT/01.04. p. 25.
15. Pruss A, Giroult E, Rushbrook P. Safe management of wastes from health care activities. Geneva: World Health Organization; 1999. WHO document WHO/EOS/98.6.